{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:46:05Z","timestamp":1792374365975,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pnpbp.2025.111455","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:43:50Z","timestamp":1752853430000},"page":"111455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"141","author":[{"given":"Kate","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erritzoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Muthukumaraswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2025.111455_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000361078","article-title":"Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder","volume":"83","author":"Abdallah","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cells13040318","article-title":"Astrocytic GABAergic regulation in alcohol use and major depressive disorders","volume":"13","author":"Ali","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111455_bib418","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8","article-title":"Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD\u201010 and DSM\u2010IV","volume":"14","author":"Almeida","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111455_bb0020","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.clinph.2017.06.243","article-title":"The impact of accelerated high frequency rTMS on brain neurochemicals in treatment-resistant depression: insights from (1)H MR spectroscopy [research Support, non-U.S. gov\u2019t]","volume":"128","author":"Baeken","year":"2017","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0030","article-title":"Left dorsolateral prefrontal cortex Glx\/tCr predicts efficacy of high frequency 4- to 6-week rTMS treatment and is associated with symptom improvement in adults with major depressive disorder: findings from a pilot study","volume":"12","author":"Bhattacharyya","year":"2021","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145708009516","article-title":"Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response","volume":"12","author":"Block","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pcn.12604","article-title":"Neural basis of major depressive disorder: beyond monoamine hypothesis","volume":"72","author":"Boku","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0050","article-title":"Neurometabolite changes in response to antidepressant medication: a systematic review of 1H-MRS findings","volume":"40","author":"Boucherie","year":"2023","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01243369","article-title":"Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock","volume":"56","author":"Bowdler","year":"1983","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41398-022-02304-2","article-title":"Distinct and shared patterns of brain plasticity during electroconvulsive therapy and treatment as usual in depression: an observational multimodal MRI-study","volume":"13","author":"Bracht","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pscychresns.2017.08.009","article-title":"Acute change in anterior cingulate cortex GABA, but not glutamine\/glutamate, mediates antidepressant response to citalopram","volume":"269","author":"Brennan","year":"2017","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"13","key":"10.1016\/j.pnpbp.2025.111455_bb0070","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/npp.2012.142","article-title":"The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T 1H-MRS study","volume":"37","author":"Cai","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111455_bb0075","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1017\/S0033291722000678","article-title":"Are all antidepressants the same? The consumer has a point","volume":"53","author":"Camino","year":"2023","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.267","article-title":"Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study [research Support, non-U.S. gov\u2019t]","volume":"7","author":"Cano","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0085","series-title":"Anterior Cingulate Cortex and Cerebellar Hemisphere Neurometabolite Changes in Depression Treatment: A 1H Magnetic Resonance Spectroscopy Study Controlled Clinical Trial","author":"Chen","year":"2014"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pscychresns.2015.11.005","article-title":"Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents","volume":"247","author":"Croarkin","year":"2016","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder [article]","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jad.2020.01.138","article-title":"Glutamatergic and GABA-ergic abnormalities in first-episode depression. A 1-year follow-up 1H-MR spectroscopic study","volume":"266","author":"Draganov","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0105","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1503\/jpn.150223","article-title":"Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy","volume":"41","author":"Dubin","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neubiorev.2014.07.016","article-title":"Associations of regional GABA and glutamate with intrinsic and extrinsic neural activity in humans\u2014a review of multimodal imaging studies","volume":"47","author":"Duncan","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111455_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.30773\/pi.2019.07.17.3","article-title":"Evaluation of transcranial magnetic stimulation efficiency in major depressive disorder patients: a magnetic resonance spectroscopy study","volume":"16","author":"Erbay","year":"2019","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0125","article-title":"Anterior cingulate gamma-aminobutyric acid concentrations and electroconvulsive therapy","volume":"10(11), e01833, Article e01833","author":"Erchinger","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0130","article-title":"Magnetic resonance spectroscopy in depressed subjects treated with electroconvulsive therapy\u2014a systematic review of literature [systematic review]","volume":"12","author":"Erchinger","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0135","first-page":"1155689","article-title":"Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate","volume":"14","author":"Erchinger","year":"2023","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/YCT.0000000000000766","article-title":"Association between anterior cingulate cortex neurochemical profile and clinical remission after electroconvulsive treatment in major depressive disorder: a longitudinal 1H magnetic resonance spectroscopy study","volume":"37","author":"Ermis","year":"2021","journal-title":"J. Ect"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111455_bb0145","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41386-018-0057-1","article-title":"7T (1)H-MRS in major depressive disorder: a ketamine treatment study","volume":"43","author":"Evans","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpsychires.2018.08.015","article-title":"Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: a systematic review and meta-analysis","volume":"105","author":"Godfrey","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2021.111377","article-title":"Effect of rTMS on GABA and glutamate levels in treatment-resistant depression: An MR spectroscopy study","volume":"317","author":"Godfrey","year":"2021","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-014-3687-y","article-title":"Neurochemistry of major depression: a study using magnetic resonance spectroscopy","volume":"232","author":"Godlewska","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0165","article-title":"Repetitive transcranial magnetic stimulation-associated changes in neocortical metabolites in major depression: a systematic review","volume":"35","author":"Gonsalves","year":"2022","journal-title":"NeuroImage: Clin."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111455_bb0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jpsychires.2012.04.018","article-title":"Region-specific glutamate changes in patients with unipolar depression","volume":"46","author":"Grimm","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuron.2007.06.026","article-title":"Transcranial magnetic stimulation: a primer","volume":"55","author":"Hallett","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bib419","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0180","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1. 0. The Cochrane Collaboration. 2011. In","author":"Higgins","year":"2011"},{"issue":"7414","key":"10.1016\/j.pnpbp.2025.111455_bb0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0190","doi-asserted-by":"crossref","first-page":"19907","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report","volume":"65","author":"Husain","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0195","series-title":"Glutamine Synthetase: Role in Neurological Disorders","first-page":"327","author":"Jayakumar","year":"2016"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/acps.12462","article-title":"Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression","volume":"133","author":"Jorgensen","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/neu.2018.22","article-title":"Magnetic resonance (MR) spectroscopic measurement of gamma-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy","volume":"31","author":"Knudsen","year":"2019","journal-title":"Acta Neuropsychiatr"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111455_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1503\/jpn.180230","article-title":"Dorsolateral prefrontal gamma-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy","volume":"44","author":"Levitt","year":"2019","journal-title":"J. Psychiatry Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0215","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10334-016-0526-7","article-title":"Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 tesla","volume":"29","author":"Li","year":"2016","journal-title":"MAGMA"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111455_bb0220","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jpsychires.2006.02.003","article-title":"Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression","volume":"41","author":"Luborzewski","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.mri.2005.12.023","article-title":"Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T","volume":"24","author":"Mangia","year":"2006","journal-title":"Magn. Reson. Imaging"},{"issue":"4284","key":"10.1016\/j.pnpbp.2025.111455_bb0235","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1126\/science.14400","article-title":"Glutamine synthetase: glial localization in brain","volume":"195","author":"Martinez-Hernandez","year":"1977","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0240","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16cs10905","article-title":"Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression","volume":"79","author":"McClintock","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2009.04.027","article-title":"Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations","volume":"219","author":"Merkl","year":"2009","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111455_bb0250","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.biopsych.2010.08.009","article-title":"Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy","volume":"69","author":"Merkl","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111455_bb0255","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111455_bb0260","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291703007931","article-title":"Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression","volume":"33","author":"Michael","year":"2003","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111455_bib416","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","article-title":"Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA","volume":"86","author":"Mullins","year":"2014","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpsychires.2008.04.009","article-title":"The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study","volume":"43","author":"Murck","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111455_bb0275","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0269881116639298","article-title":"\u0393-Aminobutyric acid as a metabolite: interpreting magnetic resonance spectroscopy experiments","volume":"30","author":"Myers","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111455_bb0280","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/s41380-022-01730-4","article-title":"Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial [article]","volume":"27","author":"Narayan","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111455_bb0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1503\/jpn.150177","article-title":"Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression","volume":"42","author":"Njau","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0290","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0924-977X(99)00030-9","article-title":"Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders","volume":"9","author":"Nutt","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0295","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors","volume":"86","author":"Orser","year":"1997","journal-title":"J. Am. Soc. Anesthesiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4927(03)00003-9","article-title":"Effective electroconvulsive therapy reverses glutamate\/glutamine deficit in the left anterior cingulum of unipolar depressed patients","volume":"122","author":"Pfleiderer","year":"2003","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0305","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/appi.ajp.2014.14010076","article-title":"Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches","volume":"172","author":"Phillips","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnmrs.2011.06.001","article-title":"In vivo magnetic resonance spectroscopy of GABA: a methodological review","volume":"60","author":"Puts","year":"2012","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111455_bb0315","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/13894501113149990156","article-title":"Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue","volume":"14","author":"Rajkowska","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pnpbp.2025.111455_bib420","series-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria","year":"2021"},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111455_bb0325","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.81.20.6330","article-title":"Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo","volume":"81","author":"Rothman","year":"1984","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111455_bb0330","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0335","unstructured":"Ryan, R. (2016). Heterogeneity and subgroup analyses in Cochrane consumers and communication review group reviews: Planning the analysis at protocol stage. Cochrane Consum Commun Rev Gr 2014. Cochrane website. In."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111455_bb0340","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0350","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopsych.2005.07.015","article-title":"Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy","volume":"59","author":"Sanacora","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0355","first-page":"75","article-title":"Study on dorsolateral prefrontal cortex neurochemical metabolite levels of patients with major depression using H-MRS technique","volume":"31","author":"Sendur","year":"2020","journal-title":"Turk Psikiyatri Derg."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0360","doi-asserted-by":"crossref","first-page":"113953","DOI":"10.1016\/j.psychres.2021.113953","article-title":"A preliminary study of the association of increased anterior cingulate gamma-aminobutyric acid with remission of depression after ketamine administration","volume":"301","author":"Singh","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2025.111455_bb0365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jad.2020.10.011","article-title":"Neurotransmitters and Neurometabolites in late-life depression: a preliminary magnetic resonance spectroscopy study at 7T","volume":"279","author":"Smith","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111455_bib417","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The structured clinical interview for DSM-III-R (SCID): I: history, rationale, and description","volume":"49","author":"Spitzer","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9360","key":"10.1016\/j.pnpbp.2025.111455_bb0370","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK Ect Review Group","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111455_bb0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111455_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"issue":"9995","key":"10.1016\/j.pnpbp.2025.111455_bb0385","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2025.111455_bb0390","doi-asserted-by":"crossref","first-page":"1025882","DOI":"10.3389\/fnins.2022.1025882","article-title":"Quantitative magnetic resonance spectroscopy of depression: the value of short-term metabolite changes in predicting treatment response [article]","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/YCT.0000000000000094","article-title":"Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series","volume":"30","author":"Yang","year":"2014","journal-title":"J. Ect"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111455_bb0400","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","article-title":"Convergent mechanisms underlying rapid antidepressant action","volume":"32","author":"Zanos","year":"2018","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111455_bb0405","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111455_bb0410","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.pnpbp.2010.06.009","article-title":"High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression","volume":"34","author":"Zheng","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111455_bb0415","doi-asserted-by":"crossref","first-page":"pyv059","DOI":"10.1093\/ijnp\/pyv059","article-title":"Abnormal anterior cingulate N-Acetylaspartate and executive functioning in treatment-resistant depression after rTMS therapy","volume":"18","author":"Zheng","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462500209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462500209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:30:49Z","timestamp":1765913449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462500209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":87,"alternative-id":["S027858462500209X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111455","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111455"}}